Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- história familiar de neuropatia, pés cavos ou marcha irregular
- dificuldades para caminhar
- pés cavos
- marcha em steppage
- arreflexia ou hiporreflexia difusa do tendão profundo
- força muscular reduzida
- sensação reduzida
- sintomas sensoriais temporários
- sintomas motores temporários
Outros fatores diagnósticos
- cirurgia prévia nos pés e tornozelos
- dificuldades de equilíbrio na infância
- fraqueza do tornozelo
- anormalidades sensoriais nas mãos e nos pés
- marcha digitígrada
- marcos motores tardios sem deambulação
- ataxia sensorial
- cifoescoliose
Fatores de risco
- história familiar de neuropatia, pés cavos (arcos dos pés elevados com pododáctilos em martelo) ou marcha irregular
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- estudos de condução nervosa (ECN)
Investigações a serem consideradas
- teste genético
- radiografia do quadril
- teste de função pulmonar
Algoritmo de tratamento
todos os pacientes
Colaboradores
Autores
Carly E. Siskind, MS, CGCL
Clinical Assistant Professor (Affiliated)
Certified Genetic Counselor
Stanford Health Care
Stanford University
Stanford
CA
Declarações
CES has an unpaid position on the Charcot Marie Tooth Association Advisory Board and is part of the Charcot Marie Tooth Disease Gene Curation Expert Panel for ClinGen. CES is a volunteer member of the Pediatric Best Practices for Charcot Marie Tooth disease panel. CES has received institutional funding from an Inherited Neuropathies Consortium research grant, funded by the Muscular Dystrophy Association and the National Institute for Health. CES was a volunteer speaker at the Charcot Marie Tooth Association Annual Patient and Family Conference 2021. CES has professional relationships with some authors of references cited in this topic.
Agradecimentos
Dr Carly E. Siskind would like to gratefully acknowledge Prof Richard A Lewis, her previous co-contributor to this topic.
Declarações
RAL is a consultant for Pharnext, CSL Behring, and Axelacare. He is on the Medical Advisory Board for GBS-CIDP Foundation, MGFA, and MGF of Ca. He has done expert testimony related to GBS, CIDP, and other neurologic disorders, and educational talks for AAN, AANEM, CSL Behring, and Optioncare. With the exception of Pharnext, none of these relationships are related to Charcot-Marie-Tooth disease. RAL is an author of a number of references cited in this topic.
Revisores
Pavel Seeman, MD, PhD
Associate Professor (Doc)
Head of the DNA Laboratory
Department of Child Neurology
Second School of Medicine
Charles University
Prague
and University Hospital Motol
Prague
Czech Republic
Declarações
PS declares that he has no competing interests.
Kinga Szigeti, MD, PhD
Assistant Professor
Department of Neurology and Molecular and Human Genetics
Baylor College of Medicine
Neurosensory Center
Houston
TX
Declarações
KS is an author of a reference cited in this topic.
Diagnósticos diferenciais
- Neuropatia diabética
- Polineuropatia desmielinizante inflamatória crônica
- Neuropatia periférica adquirida
Mais Diagnósticos diferenciaisDiretrizes
- Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease
- Guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders
Mais DiretrizesFolhetos informativos para os pacientes
Osteoartrite
Diabetes: o que posso fazer para me manter saudável?
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal